BST08

· BioSyngen Pte Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BST08, covering 2024-10-16 to 2024-10-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study on the Safety and Efficacy of BST08 in Treating Advanced Non-Small Cell Lung Cancer [NA]